NGF-mediated transcriptional targets of p53 in PC12 neuronal differentiation

被引:45
作者
Brynczka, Christopher
Labhart, Paul
Merrick, B. Alex [1 ]
机构
[1] NIEHS, NIH, Res Triangle Pk, NC 27709 USA
[2] N Carolina State Univ, Dept Environm & Mol Toxicol, Raleigh, NC 27606 USA
[3] Genpathway Inc, San Diego, CA 92121 USA
关键词
D O I
10.1186/1471-2164-8-139
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: p53 is recognized as a critical regulator of the cell cycle and apoptosis. Mounting evidence also suggests a role for p53 in differentiation of cells including neuronal precursors. We studied the transcriptional role of p53 during nerve growth factor-induced differentiation of the PC12 line into neuron-like cells. We hypothesized that p53 contributed to PC12 differentiation through the regulation of gene targets distinct from its known transcriptional targets for apoptosis or DNA repair. Results: Using a genome-wide chromatin immunoprecipitation cloning technique, we identified and validated 14 novel p53-regulated genes following NGF treatment. The data show p53 protein was transcriptionally activated and contributed to NGF-mediated neurite outgrowth during differentiation of PC12 cells. Furthermore, we describe stimulus-specific regulation of a subset of these target genes by p53. The most salient differentiation-relevant target genes included wnt7b involved in dendritic extension and the tfcp214/grhl3 grainyhead homolog implicated in ectodermal development. Additional targets included brk, sdk2, sesn3, txnl2, dusp5, pon3, lect1, pkcbpb15 and other genes. Conclusion: Within the PC12 neuronal context, putative p53-occupied genomic loci spanned the entire Rattus norvegicus genome upon NGF treatment. We conclude that receptor-mediated p53 transcriptional activity is involved in PC12 differentiation and may suggest a contributory role for p53 in neuronal development.
引用
收藏
页数:17
相关论文
共 94 条
  • [81] Inositol- and folate-resistant neural tube defects in mice lacking the epithelial-specific factor Grhl-3
    Ting, SB
    Wilanowski, T
    Auden, A
    Hall, M
    Voss, AK
    Thomas, T
    Parekh, V
    Cunningham, JM
    Jane, SM
    [J]. NATURE MEDICINE, 2003, 9 (12) : 1513 - 1519
  • [82] Dual-specificity phosphatase 5 (DUSP5) as a direct transcriptional target of tumor suppressor p53
    Ueda, K
    Arakawa, H
    Nakamura, Y
    [J]. ONCOGENE, 2003, 22 (36) : 5586 - 5591
  • [83] Deacetylation of p53 after nerve growth factor treatment in PC12 cells as a post-translational modification mechanism of neurotrophin-induced tumor suppressor activation
    Vaghefi, H
    Neet, KE
    [J]. ONCOGENE, 2004, 23 (49) : 8078 - 8087
  • [84] Signaling pathways for PC12 cell differentiation: Making the right connections
    Vaudry, D
    Stork, PJS
    Lazarovici, P
    Eiden, LE
    [J]. SCIENCE, 2002, 296 (5573) : 1648 - 1649
  • [85] P53 and prognosis: New insights and further complexity
    Vousden, KH
    Prives, C
    [J]. CELL, 2005, 120 (01) : 7 - 10
  • [86] p53 activity is essential for normal development in Xenopus
    Wallingford, JB
    Seufert, DW
    Virta, VC
    Vize, PD
    [J]. CURRENT BIOLOGY, 1997, 7 (10) : 747 - 757
  • [87] Dickkopf-1, an inhibitor of the Wnt signaling pathway, is induced by p53
    Wang, J
    Shou, J
    Chen, XB
    [J]. ONCOGENE, 2000, 19 (14) : 1843 - 1848
  • [88] A global map of p53 transcription-factor binding sites in the human genome
    Wei, CL
    Wu, Q
    Vega, VB
    Chiu, KP
    Ng, P
    Zhang, T
    Shahab, A
    Yong, HC
    Fu, YT
    Weng, ZP
    Liu, JJ
    Zhao, XD
    Chew, JL
    Lee, YL
    Kuznetsov, VA
    Sung, WK
    Miller, LD
    Lim, B
    Liu, ET
    Yu, Q
    Ng, HH
    Ruan, YJ
    [J]. CELL, 2006, 124 (01) : 207 - 219
  • [89] THE P53 MDM-2 AUTOREGULATORY FEEDBACK LOOP
    WU, XW
    BAYLE, JH
    OLSON, D
    LEVINE, AJ
    [J]. GENES & DEVELOPMENT, 1993, 7 (7A) : 1126 - 1132
  • [90] Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer
    Xi, YG
    Shalgi, R
    Fodstad, O
    Pilpel, Y
    Ju, JF
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (07) : 2014 - 2024